Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer
Go back to Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer| (NASDAQ: IMUX) | Delayed: 9.37 -1.47 (13.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.84 | 52 Week High | $ | |||
| Open | $10.85 | 52 Week Low | $ | |||
| Day High | $11.12 | P/E | N/A | |||
| Day Low | $9.36 | EPS | $ | |||
| Volume | 662,159 | |||||

